Antidepressant-like effect of low molecular proanthocyanidin in mice: Involvement of monoaminergic system

Pharmacology Biochemistry and Behavior

Volumn 94, Issue 3, 2010, Pages 447-453

  Xu, Ying ^a   Li, Shan ^a,b   Chen, Ruijie ^b   Li, Gaowen ^b   Barish, Philip A ^a   You, Wenting ^b   Chen, Ling ^b   Lin, Mengmeng ^b   Ku, Baoshan ^c   Pan, Jianchun ^b   Ogle, William O ^a  

^a University of Florida   (United States)

^b WENZHOU MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Forced swimming; Locomotor activity; Monoamine; Monoamine oxidase; Proanthocyanidin; Tail suspension

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; DOPAMINE; IMIPRAMINE; MOCLOBEMIDE; NEUROTRANSMITTER; NORADRENALIN; PROANTHOCYANIDIN; SEROTONIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN TISSUE; CONTROLLED STUDY; DEPRESSION; DOPAMINE BRAIN LEVEL; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG MECHANISM; ENZYME INHIBITION; FORCED SWIMMING TEST; FRONTAL CORTEX; GRAPE; HIPPOCAMPUS; HOPELESSNESS; HYPOTHALAMUS; IMMOBILIZATION; LOCOMOTION; MALE; MOLECULAR WEIGHT; MONOAMINERGIC SYSTEM; MOUSE; NEUROCHEMISTRY; NEUROPHARMACOLOGY; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENALIN BRAIN LEVEL; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL; SINGLE DRUG DOSE;

ANIMALS; ANTIDEPRESSIVE AGENTS; BIOGENIC MONOAMINES; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; LOCOMOTION; MALE; MICE; MICE, INBRED ICR; MOLECULAR WEIGHT; MONOAMINE OXIDASE; PROANTHOCYANIDINS;

MUS; VITACEAE;

EID: 71849112936     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.10.007     Document Type: Article

References (36)

1. Aruoma O.I., Sun B., Fujii H., Neergheen V.S., Bahorun T., Kang K.S., et al. Low molecular proanthocyanidin dietary biofactor oligonol: its modulation of oxidative stress, bioefficacy, neuroprotection, food application and chemoprevention potentials. Biofactors 27 (2006) 245-265
2. Bhutani M.K., Bishnoi M., and Kulkarni S.K. Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes. Pharmacol Biochem Behav 92 (2009) 39-43
3. Blier P., and De Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15 (1994) 220-226
4. Bortolato M., Chen K., and Shih J.C. Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv Drug Deliv Rev 60 (2008) 527-1533
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72 (1976) 248-254
6. Butterweck V., Bockers T., Korte B., Wittkowski W., and Winterhoff H. Long-term effects of St John's wort and hypericin on monoamine levels in rat hypothalamus and hippocampus. Brain Res 930 (2002) 21-29
7. Chakrabarti S.K., Loua K.M., Bai C.J., Durham H., and Panisset J.C. Modulation of monoamine oxidase activity in different brain regions and platelets following exposure of rats to methylmercury. Neurotoxicol Teratol 20 (1998) 161-168
8. Clausius N., Born C., and Grunze H. The relevance of dopamine agonists in the treatment of depression. Neuropsychiatr 23 (2009) 15-25
9. Dalbo S., Jurgensen S., Horst H., Soethe D.N., Santos A.R.S., Pizzolatti M.G., et al. Analysis of the antinociceptive effect of the proanthocyanidin-rich fraction obtained from croton celtidifolius barks: evidence for a role of the dopaminergic system. Pharmacol Biochem Behav 85 (2006) 317-323
10. Elhwuegi A.S. Central monoamines and their role in major depression. Prog Neuropsychopharmacol 28 (2004) 435-451
11. Fitzpatrick D.F., Fleming R.C., Bing B., Maggi D.A., and O'-Malley R.M. Isolation and characterization of endothelium-dependent vasorelaxing compounds from grape seeds. J Agric Food Chem 48 (2000) 6384-6390
12. Franklin K.B.J., and Paxinos G. The mouse brain in stereotaxic coordinates (1997), Academic Press, San Diego, CA
13. Garcia R. Stress, metaplasticity, and antidepressants. Curr Mol Med 2 (2002) 629-638
14. Heydendael W., and Jacobson L. Differential effects of imipramine and phenelzine on corticosteroid receptor gene expression in mouse brain: potential relevance to antidepressant response. Brain Res 1238 (2008) 93-107
15. Koga T., Moro K., Nakamori K., Yamakoshi J., Hosoyama H., Kataoka S., et al. Increase o antioxidative potential of rat plasma by oral administration of proanthocyanidin-rich extract from grape seeds. J Agric Food Chem 47 (1999) 1892-1897
16. Kulkarni S.K., Bhutani M.K., and Bishnoi M. Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology 201 (2008) 435-442
17. Lee K.C., and Chen J.J. Transdermal selegiline for the treatment of major depressive disorder. Neuropsychiatr Dis Treat 3 (2007) 527-537
18. Machado D.G., Bettio L.E.B., Cunha M.P., Capra J.C., Dalmarco J.B., Pizzolatti M.G., et al. Antidepressant-like effect of the extract of rosmarinus officinalis in mice: involvement of the monoaminergic system. Prog Neuropsychopharmacol Biol Psychiatry 33 (2009) 642-650
19. Mazzio E.A., Harris N., and Soliman K.F. Food constituents attenuate oxidase activity and peroxide levels in C6 cells. Planta Med 64 (1998) 603-607
20. Naughton M., Mulrooney J.B., and Leonard B.E. A review of the role of serotonin receptors in psychiatric disorders. Hum Psychopharmacol Clin Exp 15 (2000) 397-415
21. Nemeroff CB. The burden of severe depression: a review of diagnostic challenges and treatment alternatives. J Psychiatr Res 41 (2007) 189-206
22. Nitta A., Furukawa Y., Hayashi K., Hiramatsu M., Kameyama T., and Nabeshima T. Denervation of dopaminergic neurons with 6-hydroxydopamine increases nerve growth factor content in rat brain. Neurosci Lett 144 (1992) 152-156
23. Peng N., Clark J.T., Prasain J., Kim H., White C.R., and Wyss J.M. Antihypertensive and cognitive effects of grape polyphenols in estrogen-depleted, female, spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 289 (2005) 771-775
24. Preuss H.G., Wallerstedt D., Talpur N., Tutuncuoglu S.O., Echard B., Myers A., et al. Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: a pilot study. J Med 31 (2000) 227-246
25. Porsolt R.D., Bertin A., and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229 (1977) 327-336
26. Porsolt R.D., Bertin A., and Jalfre M. Behavioural despair in rats and mice: strain differences and the effects of imipramine. Eur J Pharmacol 51 (1978) 291-294
27. Sato M., Bagchi D., Tosaki A., and Das D.K. Grape seed proanthocyanidin reduces cardiomyocyte apoptosis by inhibiting ischemia/reperfusion-induced activation of JNK-1 and C-JUN. Free Radic Biol Med 31 (2001) 729-737
28. Steru L., Chermat R., Thierry B., and Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85 (1985) 367-370
29. Thachil A.F., Mohan R., and Bhugra D. The evidence base of complementary and alternative therapies in depression. J Affect Disord 97 (2007) 23-35
30. Uchida S., Hirai K., Hatanaka J., Hanato J., Umegaki K., and Yamada S. Antinociceptive effects of St. John's wort, Harpagophytum procumbens extract and grape seed proanthocyanidins extract in mice. Biol Pharm Bull 31 (2008) 240-245
31. Xia X., Cheng G., Pan Y., Xia Z.H., and Kong L.D. Behavioral, neurochemical and neuroendocrine effects of the ethanolic extract from Curcuma longa L. in the mouse forced swimming test. J Ethnopharmacol 110 (2007) 356-363
32. Xu Y., Ku B.S., Yao H.Y., Lin Y.H., Ma X., Zhang Y.H., et al. Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacol Biochem Behav 82 (2005) 200-206
33. Xu Y., Ku B.S., Yao H.Y., Lin Y.H., Ma X., Zhang Y.H., et al. The effects of curcumin on depressive-like behaviors in mice. Eur J Pharmacol 518 (2005) 40-46
34. Youdim M.B.H., and Weinstock M. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation. Neurotoxicology 25 (2004) 243-250
35. Yu P.H., Davis B.A., and Boulton A.A. Aliphatic propargylamine: potent, selective, irreversible monoamine oxidase B inhibitors. J Med Chem 35 (1992) 3705-3713
36. Yu Z.F., Kong L.D., and Chen Y. Antidepressant activity of aqueous extracts of Curcuma longa in mice. J Ethnopharmacol 83 (2002) 161-165